Analyze Glycans Up To 5X Faster than HILIC

Video

Obtaining high resolution glycan data has traditionally required patience. Typical analysis methods can take up to a full day. Not any longer. SCIEX Fast Glycan Labeling and Analysis delivers rapid glycan heterogeneity identification, capable of profiling your glycans in record time. Combining simplified sample preparation, rapid separations and automated glycan identification, you can make confident decisions quickly by running glycans up to five-times faster than HILIC.

Watch Now

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

Read more

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

Read more

Flow Cytometry Survey

Product Survey

If you currently use a flow cytometer or are planning to in the near future we would appreciate your feedback. We estimate the survey will take about 5-10 minutes to complete.

Read more
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

Read more
 
Hypothalamic Stem Cells Control Speed of Ageing
News

Researchers have found that stem cells in the brain’s hypothalamus govern how fast aging occurs in the body, which could lead to new strategies for warding off age-related diseases and extending lifespan.

Read more

CRISPR Used to Prevent Development of Angiogenesis of the Retina
News

Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.

Read more

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?
News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

Read more